Health ❯ Healthcare

Side Effects

Medication Risks Medication Side Effects Gastrointestinal Issues Adverse Reactions Common Side Effects Drug Safety Drug Interactions Vaccine Reactions Drug Reactions Drug Side Effects

Study Finds Small Increased Hair‑Loss Risk with GLP‑1 Drugs

Regulators are reviewing hundreds of patient reports as researchers test whether rapid weight loss or nutrient shortfalls explain the association.

EU Advisers Back Susvimo Implant as New Option for Wet Age‑Related Macular Degeneration

NHS GP Advises Waiting 48–72 Hours Before Taking Ibuprofen After Sprains or Breaks

Landsberg Patients Report Dozens of Kilograms Lost on GLP‑1 Weight Injections

MHRA Approves Wegovy Weight‑Loss Tablet as Private Demand Soars

MHRA Recalls Batch of Ramipril 2.5mg After Packaging Error

Lilly’s Triple‑Agonist Retatrutide Produces Surgery‑Level Weight Loss in Phase 3 Trial

FDA Approves Bizengri for NRG1 Fusion-Positive Cholangiocarcinoma

Moderna’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

UK Flags Safety Profile of GLP-1 Weight-Loss Jabs as One in 10 Report Digestive Side Effects

EMA Backs First Combined COVID-19 and Flu Vaccine for Over-50s in EU

EU Regulators Back First Combined COVID-19 and Flu mRNA Shot for Adults 50 and Over

EMA Backs First Combined COVID–Flu Vaccine for People 50 and Over

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

WHO-Backed Reviews Affirm GLP-1 Weight-Loss Gains as Clinicians Flag Safety and Nutrition Gaps

NHS Renews Warnings on PPIs, Sets OTC Pantoprazole Limits

UK Regulator Adds Rare Vision‑Loss Warning to Ozempic, Wegovy and Rybelsus